How a local doctor and a ‘life-changing' class are helping people lead healthy lives
DES MOINES, Iowa — Metabolic dysfunction may be the most serious condition you've never heard of, and one in three Americans have it. That's the bad news. The good news is preventing it is actually pretty simple.
'We have made it way too complicated,' says Dr. Andy Nish. 'And why is that? Because we're always trying to sell something, right?'
Nish has been practicing medicine for nearly 40 years, but it wasn't until he was more than two decades into his career that he started studying nutrition, stress and sleep, all because of the alarming increase in cancer rates. Now, he's teaching a class called 'Aspire' in an effort to help people help themselves.
'It's not about just food. It's not just about movement. It's not just about, you know, what's in our food system,' he explains, 'It's about this concept called the exposome. And the exposome is everything we are exposed to from the time of birth till the time of death.'
Annie McCormick was in the pilot class two years ago.
'I knew I needed it,' she says. 'I'm diabetic and at that point I was a bad diabetic and I needed help.' She's been to every class since. 'Well, you learn something new in every class, or it's said a little bit different than it was said in the first class. So, you're going, 'Oh, yeah.' You know, the light bulb will go off.'
Dr. Nish explains what healthy aging is and how we can achieve it
Tim McCoy loves seeing those light bulb moments. He's the reason the Aspire class exists.
'I thought, well, hey, could you come and be the medical director for this new thing? We didn't have a name at the time. Yeah. So that was two and a half, almost two and a half years ago. '
Heather Charlson has also been there from the beginning.
'Oh, I've learned that it's more than just what people think it is, whether it's just nutrition and exercise. There's so many more things that go into it, whether it's your sleep quality, dealing with stress management or relationships.'
Big picture – that's called 'metabolic health' and many things can impact it. Metabolic dysfunction is when at least three of these symptoms are present — increased waist size, elevated blood triglycerides, low HDL cholesterol, high blood pressure, and elevated blood sugar. Those things increase the risk of having cardiovascular disease, diabetes, liver disease, kidney disease, and sleep apnea. Those conditions increase your risk of dying. That's why new participants start the class with specific screenings.
'And as I explain to people, that blood test is not the end all, be all. We're not trying to change a blood test,' explains Dr. Nish, 'we're trying to change how you feel. How do you feel emotionally? How's your energy level?'
The blood test may not tell the whole story, but it's definitely part of it. Annie lowered her A1C from eleven down to five, just one indicator of better health.
'When people are suffering, it's just it's very rewarding to see,' says Tim McCoy, 'changing lives, that's what it's about.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Trump's EPA announces major rollbacks to power plant pollution limits
US power plants will be allowed to pollute nearby communities and the wider world with more unhealthy air toxins and an unlimited amount of planet-heating gases under new regulatory rollbacks proposed by Donald Trump's administration, experts warned. The US Environmental Protection Agency (EPA) unveiled a plan on Wednesday that would repeal a landmark climate rule that aims to mostly eliminate greenhouse gases from power plants by the 2030s and would, separately, weaken another regulation that restricts power plants' release of hazardous air pollutants such as mercury. 'We choose to both protect the environment and grow the economy,' said Lee Zeldin, administrator of the EPA, at an event to announce the plans. He said the rollbacks will save households money while also defying what he called 'the climate change cult'. The climate rule has 'saddled our critical power sector with expensive, unreasonable and burdensome regulations', Zeldin said. 'American energy suffered and Americans who rely on reliable, affordable energy suffered. The good news is those days are over.' The EPA's proposals will go out for public comment and are likely to face legal challenges. They target a rule crafted last year by the Biden administration to phase out emissions from electricity-producing fossil fuel plants, which are responsible for around a quarter of US greenhouse gases, and a regulation called the Mercury and Air Toxics Standards, which Biden toughened in 2023 to slash harmful pollution suffered by communities. These rollbacks come despite overwhelming scientific evidence of the dire consequences of the worsening climate crisis and the harm caused by pollutants such as mercury, which can seep into water, soils and the air and has been linked to neurological damage in young children as well as heart, lung and immune system ailments in adults. Coal-fired power plants cause nearly half of all mercury emissions in the US, according to the EPA. More than 200 health experts wrote to the EPA on Wednesday warning the moves 'would lead to the biggest pollution increases in decades and is a blatant give-away to polluters'. The experts added the reversals are 'a direct contradiction to the Environmental Protection Agency's mission of protecting public health and the environment'. Trump, however, has vowed to boost fossil fuel production at all costs, having reaped record donations from the oil and gas industry during his election campaign. At Wednesday's EPA event, Zeldin was joined by eight lawmakers, all Republicans – Kevin Cramer, Troy Balderson, Brett Guthrie, Carol Miller, Dan Meuser, Rob Bresnahan, Michael Rulli and Riley Moore – who have collectively received more than $3m from fossil fuel donors in their own election campaigns, a Guardian analysis of the OpenSecrets database shows. Bresnahan, a Pennsylvania representative, holds personal financial interests in more than 20 fossil fuel companies. In justifying the deletion of the Biden climate plan, which the EPA previously estimated would deliver $370bn in net benefits, Zeldin has claimed that US power plants only produce a small and declining fraction of the world's emissions. This is despite the fact that if these power plants were a country, it would be the sixth-largest emitter on the planet. Gina McCarthy, who was EPA administrator under Barack Obama, said that Zeldin's 'dismantling of our nation's protections from power plant pollution is absolutely illogical and indefensible. It's a purely political play that goes against decades of science and policy review.' 'By giving a green light to more pollution, his legacy will forever be someone who does the bidding of the fossil fuel industry at the expense of our health,' she added. 'Everyone will be affected by his actions, but the most vulnerable among us, our kids and grandkids, will suffer the most.' The EPA has embarked upon a wide-ranging blitz upon environmental regulations since Trump became president, setting about removing or loosening clean air and water rules that, collectively, were on track to save 200,000 American lives in the decades ahead. Trump, who has adopted the mantra of 'drill, baby, drill', has claimed unhindered fossil fuel production will bring down energy costs, although he has sought to hobble clean energy such as solar and wind, which are typically the cheapest sources of new electricity generation. The rollbacks follow the second-hottest May on record globally, and a record-hot 2024 that unleashed a stunning number of climate-driven disasters and six weeks of extra-dangerously hot days. Experts have warned that sea level rise is on track to cause 'catastrophic inland migration', including to millions of Americans, with climate shocks set to wipe 50% from global GDP by the end of this century. 'It's completely reprehensible that Donald Trump would seek to roll back these lifesaving standards and do more harm to the American people and our planet just to earn some brownie points with the fossil fuel industry,' said Patrick Drupp, climate policy director at the Sierra Club. 'This administration is transparently trading American lives for campaign dollars and the support of fossil fuel companies, and Americans ought to be disgusted and outraged that their government has launched an assault on our health and our future.'
Yahoo
3 hours ago
- Yahoo
Opinion - Trump has a historic opportunity to save lives in the fentanyl crisis
Something extraordinary is happening in the American overdose crisis. Recent federal data show that annual drug overdose deaths fell by 27 percent in 2024. This marks an unprecedented reversal after two decades of almost uninterrupted increases in overdose deaths. Overdose deaths were initially driven by prescription opioids in the 1990s, began to shift toward heroin in the early 2010s and, since 2015, have been driven mostly by illicit fentanyl. There's still a long way to go in the overdose crisis. More than 80,000 people are still dying annually of overdose, roughly the number heading into the COVID-19 pandemic when the fentanyl crisis was already raging. But the Trump administration now has an extraordinary opportunity to achieve a lasting public health victory. To its credit, the administration has been vocal about the threat posed by fentanyl. Within hours of reentering the White House, Trump pushed fentanyl to the center of his trade disputes with China and Mexico. The administration was correct to press China to clamp down on trafficking in fentanyl precursors and pressuring Mexico to eradicate cartel-run clandestine labs. Meanwhile, Attorney General Pam Bondi has prominently touted the success of Drug Enforcement Administration law enforcement operations, publicizing major drug busts and tying these actions to border control. The Biden White House had also been engaging in diplomatic efforts to reduce the fentanyl supply and to disrupt cartels. Research suggests that focused law enforcement operations can disrupt drug markets, at least over the short term. The problem is that these gains can be hard to sustain. Clandestine labs can be shut down, only to reopen the next day. Fentanyl is potent, compact and easy to manufacture with simple kitchen tools. Intercepting shipments at the southern border has proven incredibly challenging — a single kilogram brick concealed in a car can supply the ingredients for 500,000 pressed pills. Supply reductions won't work without a focus on decreasing demand for fentanyl. Almost six million Americans have an opioid addiction, often sustained by using multiple times a day. Somewhat paradoxically, squeezing supply can increase the risk of fatal overdose. If the Trump administration could squash the flow of fentanyl today, there would be millions of Americans who would be sick with opioid withdrawal tomorrow. For a fortunate few who are able to give up opioids 'cold turkey,' a rapid decrease in supply would be just what they need to stop using. But this strategy won't work for most people who are seriously dependent on fentanyl. If and when they return to using fentanyl, they will have lower tolerance and be at much higher risk of death. The good news is that there is a public health toolbox to help people with opioid addiction — tools that have undeniably contributed to the recent drop in overdose deaths. Medications like methadone and buprenorphine treat the core symptoms of opioid addiction, such as craving and withdrawal. Medications cut overdose risk by more than half compared to treatment without medication. Naloxone paired with overdose education has been incredibly effective not only as a tool for first responders but for people who use drugs and their social networks. For people who are still actively using drugs, fentanyl test strips and safer use supplies can guide more informed choices about whether and how to use drugs. Test strips are particularly useful for people who, for example, recreationally use cocaine and are seeking to avoid potent opioids. The administration has endorsed these tools. The White House Office of National Drug Control gave medication treatment, naloxone and test strips a prominent place next to law enforcement in their first priorities. Health and Human Services Secretary Robert F. Kennedy Jr. has also supported methadone and buprenorphine. But rhetoric won't work without resources. DOGE has already downsized the Substance Abuse and Mental Health Services Administration, reducing the scope of its operations through staff reductions and cuts to grants. The White House now proposes to eliminate the agency altogether and absorb it into a new Administration for a Healthy America. The SUPPORT Act, a bipartisan law that funds state and local government responses to the overdose crisis, just passed a renewal vote on the House floor. Congress, at the same time, is debating the most consequential cuts to Medicaid spending in decades in Trump's 'big beautiful bill,' putting in jeopardy the primary source of coverage that has expanded access to addiction treatment for millions of low-income Americans. There's still time for an 'Aha' moment. Cracking down on international drug cartels was a good start, but maintaining resources to treat Americans with active addiction is needed to sustain the drop in overdose deaths. Doing so would not only be smart politics — it would also live up to the promise of making America healthier. Brendan Saloner, Ph.D., is a Bloomberg Professor of American Health in Addiction and Overdose in the Department of Health Policy and Management in the Johns Hopkins University School of Public Health. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
The Hill
3 hours ago
- The Hill
We're cancer doctors. Here's why Medicare Advantage fails America's elderly.
'It's nothing,' Tom, a retired firefighter from rural Texas, thought when he had persistent stomach pain. After shedding 30 pounds in three weeks, his family physician ordered a CT scan. Tom was not concerned — after all, the 65-year-old had gotten Medicare Advantage earlier that year. Like millions, Tom switched his insurance after he was solicited by a broker who promised low premiums and a gift card. Absent from the sales pitch was the fact that Medicare Advantage plans — privately run and separate from government-funded traditional Medicare — often delay and deny coverage. One of us met Tom nearly three months after his CT scan, and his doctor discovered the abdominal mass. The job as the first oncologist he had been able to see after months of jumping through hoops was to get initial scans, identify an in-network provider, wait for further referral and approval processes and finally schedule and complete a biopsy. The delays became a death knell. Tom was diagnosed with Stage 3 pancreatic cancer. Tom's first question was, 'It's going to be fine, right?' Despite the urge to reassure him, Tom's life and treatment options were not up to a doctor. They were up to his insurance. The same insurance that delayed urgent testing and care. By definition, Medicare Advantage is meant to support elderly medical care and increase efficiencies; in function, it is a business model that allows the American government to decrease its liability for sick seniors. Instead of absorbing and managing costs, the responsibility is outsourced to third-party operators, such as UnitedHealth Group, Humana and CVS Health. While Medicare Advantage provides excellent coverage if you never get sick, this insurance can quickly become a precursor to medical bankruptcy if the patient develops a deadly disease, a highly probable outcome when you consider that nearly 40 percent of Americans get cancer in their lifetime. After nearly two decades of experimentation and $450 billion of taxpayer money, Medicare Advantage has proven porous in terms of corruption, fraud and abuse. Yet, 32.8 million elderly Americans (54 percent of the eligible Medicare population) are currently enrolled in Medicare Advantage. In 2023 alone, Medicare Advantage plans fully or partially denied 3.2 million prior authorization requests. No one, especially among folks facing the daily drudgery of fighting cancer, truly understands how the cogs within the insurance machine work. Few of our elderly patients fight the goliath institution, and many succumb to poorer health outcomes in their quest for lifesaving treatment. Last year, countrywide and across disease groups, 79 percent of patients who experienced a delay or denial of coverage paid out of pocket for medication at least sometimes. Unsurprisingly, more than 100 million Americans are in medical debt. Of those who appealed between 2019 and 2023, over 80 percent were approved, implying that the initial claims were valid. This game of attrition directly contradicts Medicare Advantage's promise to provide efficient, patient-centered healthcare. These denials are not just medically dangerous because they enable deadly diseases to progress unchecked. They are also emotionally erosive. Daily, we see patients shrink in the face of denials, unable to emotionally navigate the complex Medicare system and the immense pain, isolation and depression resulting from this behemoth that stands between their disease and their hope to be free of it. During one of Tom's chemo visits, with thousands of dollars worth of IVs in his veins, his skin pale and translucent, he realized he was begging his insurance at every turn to support him. Stories like Tom's reveal the truth: Medicare Advantage is unapologetically failing its elderly cancer patients. Sick American seniors deserve more than insurance coverage in name only. We advise our patients to avoid Medicare Advantage. The better choice is traditional Medicare, plus a secondary or supplemental insurance. Often, people do not enroll in supplemental insurance because they do not understand its importance, believe they will never get sick, miss the deadline for approval without a medical exam (you must do this within three months before or after your 65th birthday), or think it is too expensive. Although supplemental insurance costs nearly $500 a month (exact amounts vary based on age and income), choosing this add-on — and paying roughly $6,000 a year — is much more affordable than Medicare Advantage's yearly out-of-pocket (potentially adding up to $8,500) and fighting for approvals for basic treatment. On Medicare Advantage, Tom quickly reached his maximum yearly out-of-pocket of $8,500, but then it reset on Jan. 1. After four months of treatment, he was responsible for paying $17,000 for 16 months of care, on top of his insurance premiums, simply to receive standard care. Of course, if you are one of the fortunate few to have never experienced illness — and we hope you are — Medicare Advantage can be a cheaper option. The question is, how can we make Medicare Advantage advantageous for the vulnerable? There is a bipartisan opportunity to change the narrative around this insurance model. During his confirmation hearing as the head of the Centers for Medicare and Medicaid Services, Mehmet Oz criticized Medicare Advantage insurers for some of their practices. Strategic change — omitting out-of-pocket costs for cancer patients, curbing insurance companies' rights to deny claims submitted by doctors and speeding up the process — along with more rigorous oversight of the program are worthwhile goals the Trump administration and Congress should take on. While Democrats and Republicans disagree on many issues, we believe we can all agree that people like Tom — and the millions of other Americans enrolled in Medicare Advantage — deserve comprehensive and just care. Dr. Pramod Pinnamaneni, MD, MBA, and Dr. Nitya Thummalachetty, DrPH, are founders of the Nau Project, a start-up dedicated to helping everyday Americans navigate the complexities of our healthcare system.
